| Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors M Mollapour, D Bourboulia, K Beebe, MR Woodford, S Polier, A Hoang, ... Molecular cell 53 (2), 317-329, 2014 | 131 | 2014 |
| THE BIOTRANSFORMATION, BIODEGRADATION, AND BIOREMEDIATION OF ORGANIC COMPOUNDS BY MICROALGAE1 Y Ghasemi, S Rasoul‐Amini, E Fotooh‐Abadi Journal of phycology 47 (5), 969-980, 2011 | 97 | 2011 |
| Chemical perturbation of oncogenic protein folding: from the prediction of locally unstable structures to the design of disruptors of Hsp90–client interactions A Paladino, MR Woodford, SJ Backe, RA Sager, P Kancherla, ... Chemistry–A European Journal 26 (43), 9459-9465, 2020 | 49 | 2020 |
| Biotransformation of monoterpenes by immobilized microalgae S Rasoul-Amini, E Fotooh-Abadi, Y Ghasemi Journal of applied phycology 23, 975-981, 2011 | 40 | 2011 |
| Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma RA Sager, SJ Backe, E Ahanin, G Smith, I Nsouli, MR Woodford, ... Nature Reviews Urology 19 (5), 305-320, 2022 | 14 | 2022 |
| Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity SJ Backe, MR Woodford, E Ahanin, RA Sager, D Bourboulia, M Mollapour The Networking of Chaperones by Co-Chaperones, 319-350, 2022 | 2 | 2022 |
| Catalytic inhibitor of Protein Phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex II in kidney cancer Cell Chem Biol 23, 2023 | 1* | 2023 |
| MP04-09 NOVEL INHIBITOR OF PRO-SURVIVAL PROTEIN PHOSPHATASE 5 (PP5) LEADS TO APOPTOSIS IN CLEAR CELL RENAL CELL CARCINOMA E Ahanin, RA Sager, SJ Backe, N Dushukyan, M Daneshvar, ... Journal of Urology 209 (Supplement 4), e36, 2023 | | 2023 |
| Pharmacological inhibition of protein phosphatase-5 and induction of the extrinsic apoptotic pathway in kidney cancer E Ahanin | | 2023 |
| Sumoylation of Protein Phosphatase 5 Regulates Phosphatase Activity And Substrate Release RA Sager, SJ Backe, DM Dunn, JA Heritz, E Ahanin, N Dushukyan, ... Available at SSRN 4352019, 2023 | | 2023 |
